Analysis of the Global Oncology Drug Delivery Market

Future Impact of Emerging Technologies

USD 4,950

* Required Fields

USD 4,950

PAY BY INVOICE

Be the first to review this product

The global oncology drug delivery market (or oncolytics market) was worth $91.00 billion in 2013 and has been growing at an annual rate of 5.0%. The market, which includes drug delivery systems for cancer therapy and cancer pain, is expected to generate $100.96 billion in 2015. The oral drug delivery systems segment accounted for an estimated 25.0% of the total global market in 2013 and will continue to grow stronger in 2015. Currently, the injectable drug delivery system segment leads the cancer drug delivery market; however, nanoparticles (including micro-needles, patches, and orals) are expected to lead the market in the future.

Table of Contents

Executive SummaryKey FindingsKey Findings (continued)Key Findings—Options in the Oncology Drug Delivery MarketScope and SegmentationKey Questions This Study Will AnswerMarket Engineering MeasurementsCEO’s PerspectiveKey Technologies to Watch3 Key PredictionsMarket OverviewMarket BackgroundMarket Segmentation Total Oncology Drug Delivery Market—Segmentation by Type of DeliveryTotal Oncology Drug Delivery Market—Segmentation by Type of Delivery (continued)Total Oncology Drug Delivery Market—Segmentation by RegionTotal Oncology Drug Delivery Market—Segmentation by Top 5 CompetitorsCancer Pain Management MarketCompetitive PlaybookNew Market OpportunitiesPipeline of Products in Oncology Drug Delivery MarketAttractiveness in Oncology Drug Delivery MarketDrivers and Restraints—Total Cancer Drug Delivery MarketMarket DriversDrivers ExplainedDrivers Explained (continued)Market RestraintsRestraints ExplainedForecast and Trends—Total Cancer Drug Delivery MarketMarket Engineering MeasurementsForecast AssumptionsRevenue ForecastRevenue Forecast by SegmentRevenue Forecast DiscussionOral or Injectable Drug Delivery Systems—New Options for Payors Oral or Injectable Drug Delivery Systems—New Options for Payors (continued)Oral or Injectable Drug Delivery Systems—New Options for Payors (continued)Oral or Injectable Drug Delivery Systems—New Options for Payors (continued)Porter’s 5 Force AnalysisInjectable Drug Delivery System Segment AnalysisMarket Engineering MeasurementsInjectable Drug Delivery System Segment—Revenue ForecastRevenue Forecast DiscussionInjectable Drug Delivery System Segment—Competitive AssessmentOral Drug Delivery System Segment AnalysisMarket Engineering MeasurementsOral Drug Delivery System SegmentRevenue Forecast DiscussionOral Oncolytic—Past, Present, and Future Options Oral Drug Delivery System Segment—Competitive AssessmentOpportunities by RegionUS Market—Overview of Oncology Drug Delivery MarketUS Oncology Drug Delivery Market—Revenue ForecastEurope Market—Overview of Cancer Drug Delivery SystemEurope Oncology Drug Delivery Market—Revenue ForecastRoW Oncology Drug Delivery Market—Overview of Cancer Drug Delivery SystemRoW Oncology Drug Delivery Market—Revenue ForecastOpportunity by TechnologyNano Drug Delivery—Future of Cancer Drug Delivery Systems Currently Marketed Nano Drug Delivery Systems—All Injectable Drug Delivery SystemsNano Drug Delivery System—SegmentationAttractive Nano Drug Delivery SystemsKey Nano Drug Delivery Systems—High Potential and Equally Attractive Technology for FutureIntra-nasal Drug Delivery—Next Option in Cancer Pain Key Companies to WatchBecton, Dickinson and Company (BD)Evotec AGJuno Therapeutics, Inc.West PharmaceuticalsNEONC Technologies Inc. (NTI)ConclusionFuture of Cancer Drugs—Drugs in Cases where Tumour will no Longer Respond to Standard TherapyConclusionsFrost & Sullivan AwardsLegal DisclaimerAppendixMarket Engineering MethodologyLearn More—Next Steps

Infographic





Keyword1

Keyword2

Keyword3

Related Research

Release Date : 19-Jun-17

Region : Asia Pacific

Release Date : 20-Apr-17

Region : Asia Pacific

Release Date : 19-Apr-17

Region : Asia Pacific

Release Date : 23-Mar-17

Region : Asia Pacific

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.